|
HS Code |
462838 |
| Generic Name | Flunixin Meglumine |
| Drug Class | Non-steroidal anti-inflammatory drug (NSAID) |
| Primary Use | Pain and inflammation management in animals |
| Route Of Administration | Intravenous, intramuscular, oral |
| Common Species | Horses, cattle, swine |
| Mechanism Of Action | Prostaglandin synthesis inhibitor |
| Onset Of Action | Within 2 hours |
| Duration Of Action | 12 to 24 hours |
| Metabolism | Primarily hepatic |
| Excretion | Mainly renal |
| Contraindications | Known hypersensitivity, animals with GI ulcers |
| Pregnancy Category | Use with caution |
| Prescription Status | Veterinary prescription only |
| Legal Status | Prescription-only in most countries |
| Storage Requirements | Store at room temperature, protect from light |
As an accredited Flunixin Meglumine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Flunixin Meglumine is packaged in a 100 mL amber glass vial with a sealed rubber stopper, labeled with dosage and handling instructions. |
| Shipping | Flunixin Meglumine is shipped in tightly sealed, clearly labeled containers, protected from light and moisture. It is classified as a pharmaceutical product and may require temperature control depending on the formulation. All shipping follows regulatory guidelines for handling veterinary drugs, with appropriate documentation and safety precautions to prevent spillage or contamination. |
| Storage | Flunixin Meglumine should be stored in a tightly closed container at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F). Protect it from light, moisture, and excessive heat. Avoid freezing. Ensure it is kept away from incompatible substances and out of reach of children and unauthorized personnel. Always follow manufacturer and regulatory guidelines for storage. |
Competitive Flunixin Meglumine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Flunixin Meglumine stands out on our product line for one simple reason: it delivers what veterinarians expect and livestock producers demand. In real-world terms, Flunixin Meglumine offers support for inflammation and pain management in animals—cattle, horses, and swine. Years of hands-on production and years overseeing every kilogram allow us to offer transparency on what goes into each batch and what users can expect when they open a package from our facility.
Our typical production batches yield a white to off-white crystalline powder, easily dissolved in water for injection-grade preparations. We keep a close eye on the active ingredient content, usually no less than 98% Flunixin Meglumine by HPLC analysis. Moisture control is not just a specification—it’s essential for handling, blend stability, and storage. Our controlled process keeps loss on drying under 2%. Heavy metal contaminants, a headache in global raw material supply chains, stay below 10 ppm, supported by third-party testing. Each batch passes sterility inspection when destined for injectable grade. Every technician understands why each number on our COA matters; we test and release only after meeting international specifications.
What separates Flunixin Meglumine from simple painkillers or generic anti-inflammatories is a proven track record in animal health. Decades of use in the field, particularly in treating fever and inflammation from bovine respiratory disease or colic in horses, give us plenty of feedback on outcomes. It isn’t just about meeting a pharmacopoeia monograph—livestock producers count on its ability to return their animals to normal behavior quickly.
Being a non-steroidal anti-inflammatory drug (NSAID), Flunixin Meglumine blocks cyclooxygenase, which tempers inflammation and controls fever without resorting to steroids. The science behind this mode of action lies at the intersection of safety and potency. On production days, we see the difference: precise weighing, blending, quality checks, and sterility procedures are central to reliable dosing and consistent results. Our technical staff has handled countless lots and seen how purity and particulate control translate into clarity of solution—an unspoken but immediate signal of quality for those preparing injections in veterinary practice.
A number of anti-inflammatory veterinary products circulate in the global market, including phenylbutazone, meloxicam, and ketoprofen. Each has its place, but these differences shape our conversations with both veterinarians and international customers.
Take phenylbutazone. Used for decades, it trends toward a longer withdrawal time and a well-documented risk of toxicity in certain animals. Many countries now restrict or ban it in food-producing animals. Meloxicam offers a longer duration of action and often enters conversations about chronic arthritis, but its slower onset steers acute users back to flunixin for situations where rapid response matters. Ketoprofen offers an alternative but lacks the widespread regulatory acceptance and practical comfort of flunixin in high-volume livestock operations.
In our daily operation, formulation consistency and stability testing set Flunixin Meglumine apart. Its solvency, rapid dissolution, and clarity keep it favored among veterinary compounding pharmacists who must formulate accurate, injectable products. Users routinely call us to ask why our Flunixin Meglumine remains consistent from batch to batch, even through international shipping and varied climates. Careful drying, filtration, and packaging on our lines directly impact this reliability.
One thing that can get lost in product brochures or specification tables is the reality of how Flunixin Meglumine gets made. Our production crew starts with pharmaceutical-grade raw materials sourced through strict supplier approval systems. We operate enclosed, ventilated reactors and filtration lines to ensure none of the material is exposed to environmental contaminants. After crystallization, the product passes through a multi-step drying and size reduction sequence. Our sieving process gives a consistent particle size, easing dissolution whether in a bulk compounding pharmacy or at a dosing station in a livestock facility. Each lot comes from a system where batch traceability is routine.
Quality goes beyond just numbers. We monitor the process every step—smell, appearance, and quick dissolution provide checks beyond what an assay reveals. Several of our technicians came up through internal apprenticeship programs and teach the newest hires how to spot subtle cues in a batch. For every shipment, especially to international partners, we conduct stability studies under local conditions because real-world field environments don’t always match the ideal storage temp in the spec sheets.
Our own experience tells us regulatory standards exist for a reason, but stopping there leaves animals, owners, and veterinarians vulnerable. We keep extensive documentation of every raw material, every operator on the line, and every test performed—because a mistake in one lot can impact far more than one farm. In the past, the industry has faced recalls due to product adulteration or cross-contamination; learning from those makes us spend more on end-to-end batch records and final product release. These requirements increase cost and complexity, but we’ve found customers return because of the predictability and safety such vigilance provides.
We invite audits from multinational animal health companies and welcome regular, unannounced inspections from regulatory authorities. Technical teams examine our solvent logs, air system records, and changeover checklists. They know that a clean, well-documented facility correlates with lower risk. The feedback we gain on these visits often shapes small adjustments in our process—like upgrading filtration systems or improving humidity controls in our packaging room.
The world doesn’t stand still. Livestock management practices, animal welfare standards, and global regulations shift constantly. Producers want to treat disease without jeopardizing milk or meat safety. Buyers—be they major feedlots, veterinary practices, or even smallholder farms—need trusted partners who stay ahead of new demands.
As the manufacturer of Flunixin Meglumine, we feel the pressure daily. Withdrawals for milk and meat have to be meticulously supported by residue studies and adherence to country-specific MRLs. Our QA staff study updated international regulations and harmonize our own standards to meet or exceed the strictest one. No one wants to see a residue violation in export markets or a recall hitting headlines; our commitment is personal, as every product reflects on the reputation we’ve established patiently over years.
We see, too, that rapid diagnostic methods, better herd health management, and more judicious use of therapeutics will only increase. Veterinarians want clear data on pharmacokinetics, duration of action, and clinical endpoints. We invest in ongoing research with independent labs and share data wherever transparency benefits broader animal welfare.
A product like Flunixin Meglumine changes hands many times before reaching its end use, but only manufacturers see the full complexity behind delivering true quality. Our export teams have learned the unique paperwork and shipping challenges each country brings. Consular legalization, unique import certificates, temperature-logging in air freight—we handle them all because finished product integrity hinges on these details. In our own loading bays, we’re as concerned about a temperature spike during a heat wave as we are about delayed customs clearance.
In certain markets—Latin America, Southeast Asia, Africa—distribution distances and climate strain packaging and storage. Our team adjusted packaging specs to increase moisture barriers and introduced tamper-evident seals not only to fight counterfeiting but also to reassure end-users the product inside is as secure as when it left our controlled environment. In more developed markets, we respond faster to queries for batch documentation or customs support, offering real-time digital access to COAs and stability data.
User feedback from the field drives changes in both scale and small details. One veterinary group struggled with clumping during reconstitution; after testing alternative excipients and adjusting drying cycles, our QC lab achieved a formulation more resistant to humidity. Other customers need large lots for high-throughput batch compounding; our plant planners adapt campaign sizes to meet both small-scale and bulk requirements without compromising traceability or quality.
Every manufacturing run of Flunixin Meglumine is an opportunity to improve. Whether through investment in automation to tighten process control, or in better training so every operator understands the importance of the end goal—animal health and product safety—we treat these changes as non-negotiable. We also run pilot batches with new raw materials to understand any potential impact before moving anywhere near full-scale production. It’s a proactive approach, informed by decades of real setbacks and hard-won successes.
The field will continue moving toward better animal welfare, tighter regulations, and rapid responses to disease outbreaks. With Flunixin Meglumine, we take ownership of every link in the chain—from sourcing and manufacturing to packaging and support—so veterinarians and producers can do their jobs with confidence, knowing the critical pain and inflammation relief they count on arrives as promised, every shipment. We believe a responsible manufacturer is never finished learning, adjusting, and improving—and that’s the difference between simply making a product and building trust that lasts through every lot and every season.
